Credit Suisse Ag Arbutus Biopharma Corp Transaction History

Credit Suisse Ag

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.91 - $2.85 $922 - $1,376	483 Added 78.03%	1,102 $2,000
Q3 2022 Nov 10, 2022	BUY	$1.88 - $2.88 $1,161 - $1,779	618 Added 61800.0%	619 $1,000
Q2 2022 Aug 12, 2022	BUY	$1.98 - $3.17 $1 - $3	1 New	1 $0
Q1 2022 May 16, 2022	SELL	$2.42 - $3.98 $27,275 - $44,858	-11,271 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.11 - $4.61 $35,052 - $51,959	11,271 New	11,271 $44,000
Q3 2021 Nov 12, 2021	SELL	$2.65 - $4.62 $229,943 - $400,882	-86,771 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.5 - $3.51 $45,987 - $64,566	-18,395 Reduced 17.49%	86,771 $262,000
Q1 2021 May 14, 2021	BUY	$3.14 - $4.84 $270,087 - $416,312	86,015 Added 449.14%	105,166 $350,000
Q4 2020 Feb 12, 2021	BUY	$2.76 - $4.97 $52,856 - $95,180	19,151 New	19,151 $68,000
Q2 2020 Aug 12, 2020	SELL	$0.91 - $2.36 $197,204 - $511,430	-216,708 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$1.01 - $3.42 $72,212 - $244,523	71,498 Added 49.24%	216,708 $219,000
Q4 2019 Feb 12, 2020	BUY	$0.87 - $2.89 $126,332 - $419,656	145,210 New	145,210 $403,000
Q3 2018 Nov 13, 2018	SELL	$7.85 - $12.35 $89,772 - $141,234	-11,436 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$5.0 - $7.35 $57,180 - $84,054	11,436 New	11,436 $84,000
Q4 2017 Feb 14, 2018	SELL	$4.45 - $7.7 $783,604 - $1.36 Million	-176,091 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.4 - $7.0 $309 - $637	91 Added 0.05%	176,091 $1.09 Million
Q2 2017 Aug 14, 2017	BUY	N/A	176,000	176,000 $634,000

157

99.6M

2.31M

525K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $507M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.